Genomate Health
Istvan Petak, MD, PhD is the Founder and CEO/CSO of Genomate Health. Istvan also serves as an Adjunct Professor at the University of Illinois Chicago and an Adjunct Lecturer at Semmelweis University. With a background in molecular pharmacodiagnostics and personalized medicine, Istvan has held various senior research and leadership positions in the field. Istvan holds a Ph.D. in Experimental Oncology from Semmelweis University and has undergone executive education in designing and implementing AI solutions for healthcare.
This person is not in any teams
Genomate Health
Genomate Health Inc. is a digital health company that develops AI-powered computational tools for personalized medicine. Our main focus is assisting physicians in making optimal personalized treatment decisions for each patient based on the complex molecular characteristics of human diseases. Our flagship product, Genomate™ MTC (Molecular Treatment Calculator), is the first computational AI solution that has been clinically proven to improve personalized N-of-1 treatment decisions in precision oncology. It automates data compilation, evaluation, and synthesis in a knowledge model allowing standardized, personalized treatment decisions based on the totality of available molecular information. We're currently partnering with cancer centers, molecular diagnostic companies, insurance companies, health funds, and pharma companies to advance access to effective targeted therapies for cancer patients worldwide. Do you want to join us?